抗精神病药物体重增加副作用的可能肠道微生物群基础
A possible gut microbiota basis for weight gain side effects of antipsychotic drugs
摘要:
体重增加是传统和新型抗精神病药物的一个公认的副作用,但原因尚不清楚。最近的研究将肥胖与肠道微生物群中存在或不存在特定基因序列相关联。我们确定了抗精神病药物的蛋白质靶点与人体中与体重调节直接相关的微生物群序列之间的强关联,从而导致潜在的宏基因组作用机制。建议进行进一步的实验研究。
英文摘要:
Weight gain is a well-established side effect of both conventional and newer anti-psychotic drugs, but the cause is not well understood. Recent studies correlate obesity with the presence or absence of particular genetic sequences in the gut microbiota. We identified strong associations between protein targets of antipsychotics and microbiota sequences directly related to weight regulation in human body, leading to a potential metagenomic mechanism of action. Further experimental study is recommended.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。